SC
MRK icon

Scotia Capital’s Merck MRK Stock Holding History

Scotia Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-209,600
Closed -$11.4M – 820
2015
Q2 		$11.4M Buy
+209,600
New +$11.8M 0.23% 83

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Scotia Capital's MRK Position: Q1 2026 in Review

Scotia Capital increased its Merck (MRK) stake by 3.5% in Q1 2026, buying an estimated $801K and bringing the position to 202,667 shares worth $24.4M. The position accounts for 0.1% of the portfolio, ranked #117.

Scotia Capital first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.8M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Scotia Capital held 202,667 shares of Merck worth $24.4M as of Q1 2026.
  • Scotia Capital bought 6,936 Merck shares in Q1 2026, an estimated $801K.
  • Merck made up 0.1% of Scotia Capital's portfolio in Q1 2026, its #117 holding.
  • Scotia Capital first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Scotia Capital's Merck position peaked at $46.8M in Q4 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.